BUPROPION HCl ER (XL)
- Product NDC
- 70756-830
- 11-digit product format
- 707560830
- Labeler code
- 70756
- Product ID
- 70756-830_ee47c513-8459-4292-b727-111b0bd1dbcc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- BUPROPION HCl ER
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Lifestar Pharma LLC
- Application
- NDA022497
- Marketing category
- NDA
- Marketing start
- 2026-05-01
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 450 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- BUPROPION HCl ER (XL)
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BUPROPION HYDROCHLORIDE | 450 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | ZG7E5POY8O |
| Rxcui | 1232585 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70756-830-16 | BUPROPION HCl ER (XL) | 16000 in 1 BOX | TABLET, EXTENDED RELEASE | 16000 | | 1 |
| 70756-830-30 | BUPROPION HCl ER (XL) | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 70756-830-16 | 70756083016 | 16000 TABLET, EXTENDED RELEASE in 1 BOX (70756-830-16) | 2026-05-01 | No | No | Current |
| 70756-830-30 | 70756083030 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70756-830-30) | 2026-05-01 | No | No | Current |